Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel tumor-directed oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
View Top Employees from Replimune| Website | http://www.replimune.com |
| Ticker | REPL |
| Revenue | $69.5 million |
| Funding | $376 million |
| Employees | 321 (289 on RocketReach) |
| Founded | 2015 |
| Address | 500 Unicorn Park Dr Fl 3, Woburn, Massachusetts 01801, US |
| Phone | (781) 222-9600 |
| Technologies |
JavaScript,
HTML,
PHP
+36 more
(view full list)
|
| Category | Biotechnology Research, Pharmaceuticals, Health Care, Biotechnology, Healthcare, Medical, Therapeutics |
| Competitors | Atara Biotherapeutics, Evelo Biosciences, Iovance Biotherapeutics Inc, Jounce Therapeutics, Inc., NextCure, Inc. |
| SIC | 873, 87 |
| NAICS | 541, 541714, 5417, 54171, 54 |
Looking for a particular Replimune employee's phone or email?
Replimune Questions
The Replimune annual revenue was $69.5 million in 2023.
Pamela Esposito is the Chief Business Officer of Replimune.
289 people are employed at Replimune.
Replimune is based in Woburn, Massachusetts.
The NAICS codes for Replimune are [541, 541714, 5417, 54171, 54].
The SIC codes for Replimune are [873, 87].
Top Replimune Employees
-
23
-
45+
-
33
-
View
Anton Trochanov
Vice President, Head of Medical Safety and Pharmacovigilance at Replimune
San Diego, CA, US35+ -
34
-
21
-
View
Nicole Luosey
VP, Portfolio Strategy and Program Management at Replimune
North Weymouth, Massachusetts, United States35+ -
32
Related Companies
